跳到主要內容

很遺憾,我們無法支援你的瀏覽器。如果可以,請升級到新版本,或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更新版本。如果無法升級,而且需要支援,請將你的回饋寄給我們。

我們衷心感謝你對這個新體驗的回饋。告訴我們你的想法

Elsevier
與我們共同出版

Embase Datasets for drug safety and pharmacovigilance

The most trusted biomedical literature for pharmacovigilance is now accessible via API.

Contact an Elsevier expert
Three pharma professionals discussing research findings in lab coats

Is your PV process effective?

Don't get left behind with your pharmacovigilance. Join the world's leading pharma and medical device companies in the switch to an AI-enabled process. Automate deduplication and train your models on better signal identification for a streamlined and revolutionary PV process.

Bring confidence to your ML-driven pharmacovigilance

Abstract gravity wave background - 3D rendered image.

Integrate Embase's gold-standard content with advanced AI to improve adverse event monitoring, better signal detection and streamlined pharmacovigilance workflows.

The world's leading source of biomedical and drug safety data

Two Female Scientists Working, Using Digital Tablet, Analysing Samples, Talking
  • Structured biomedical literature, extracted from 8.3k journals (including 3.3k not found in Medline)

  • Structured data extracted from FDA, EMA regulatory documents and literature articles

  • 2.8M extracted safety and adverse event data

Let's discuss your data needs for pharmacovigilance

Want to learn more about how the Embase API can integrate this trusted data into your automated workflows? Fill out the form below and an Elsevier expert will contact you soon to discuss how Embase Datasets can support your AI success.

你的個人資料
貴組織資料
How does your organization intend to use the Elsevier data? *